# Metformin in Diabetic Patients Undergoing Coronary Angiography

> **NCT04766008** · PHASE4 · UNKNOWN · sponsor: **Humanitas Hospital, Italy** · enrollment: 150 (estimated)

## Conditions studied

- Diabetes Mellitus
- Coronary Artery Disease
- Lactic Acidosis With Diabetes Mellitus
- Contrast-induced Nephropathy
- Metformin Associated Lactic Acidosis

## Interventions

- **DRUG:** Metformin

## Key facts

- **NCT ID:** NCT04766008
- **Lead sponsor:** Humanitas Hospital, Italy
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-01-15
- **Primary completion:** 2022-04-11
- **Final completion:** 2022-04-30
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2022-04-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04766008

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04766008, "Metformin in Diabetic Patients Undergoing Coronary Angiography". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04766008. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*